Elsevier

Hearing Research

Volume 64, Issue 1, December 1992, Pages 73-80
Hearing Research

Intracochlear salicylate reduces low-intensity acoustic and cochlear microphonic distortion products

https://doi.org/10.1016/0378-5955(92)90169-NGet rights and content

Abstract

Salicylate is well-known to produce reversible hearing loss and tinnitus. The site and mechanism of salicylate s olotoxic actions, however, remain unresolved. Recent experiments demonstrating primarily low-intensity effects on cochlear afferent outflow and effects on otoacoustic emissions (OAFs) suggest that salicylate acts to compromise active, energy-enhancing processes within the cochlea (i e, the active process). We tested this hypothesis by examining the effect of salicylale on distortion product emissions. Distortion product responses to two-tone stimulation were monitored in the guinea pig before, during, and after intracochlear administration of increasing concentrations of salnvlale (0.6–5 mM). These responses were recorded as acoustic signals in the ear canal spectrum (ADP), and as present in the cochlear microphonic (CM) recorded from a wire in basal turn scala vestibuli (CMDP). We also recorded the CM response to a single tone. Cochlear pertusion of salicylate resulted in a dose-responsive reduction in ADPs that was greater for low intensities of stimulation CMDPs also demonstrated a concentration-dependent reduction at low intensities, but were increased slightly, though not significantly, by salicylate when elicited by high intensity primaries. CM was essentially unchanged by intracochlear salicylate. These results are consistent with an action of salicylate that involves the outer hair cells (OHCs) and are in harmony with the hypothesis that salicylate may selectively compromise the active process.

References (42)

  • S.E. Barron et al.

    Cytochalasm D suppresses sound evoked potentials in the guinea pig cochlea

    Hear Res

    (1987)
  • R.P. Bobbin

    Pharmacologic approach to acoustic Lrauma in the cochlea

  • R.P. Bobbin et al.

    Effects of putative transmitters on afferent cochlear transmission

    Ann Otol Rhinol Laryngol

    (1978)
  • W.E. Brownell

    Outer hair cell electromotility and otoacoustic emissions

    Ear and Hearing

    (1990)
  • W.E. Brownell et al.

    The effect of cytoplasmic turgor pressure on the static and dynamic mechanical properties, of outer hair cells

  • W.E. Brownell et al.

    Slow electrically and chemically evoked volume changes in guinea pig outer hair cells

  • P Dallos

    Cochlear neurobiology Revolutionary developments

    ASHA

    (1988)
  • R Dieler et al.

    Concomitant salicylate-induced alterations of outer hair cell subsurface cisternae and electromotility

    J Neurocytol

    (1991)
  • B Escoubet et al.

    Prostaglandin synthesis by the cochlea of the guinea pig Influence of aspirin, gentamicin, and acoustic stimulation

    Prostaglandins

    (1985)
  • E.F. Evans et al.

    Ototoxic effects of salicylates on the responses of single cochlear nerve fibers and on cochlear potentials

    Br J Audiol

    (1982)
  • P.J. Jastreboff et al.

    Differential uptake of salicylate in serum, cerebrospinal fluid, and perilymph

    Arch Otolaryngol Head Neck Surg

    (1986)
  • Cited by (58)

    • Sodium salicylate potentiates the GABA<inf>B</inf>-GIRK pathway to suppress rebound depolarization in neurons of the rat's medial geniculate body

      2016, Hearing Research
      Citation Excerpt :

      Sodium salicylate (NaSal) can cause tinnitus in humans (Halla and Hardin, 1988; Myers and Bernstein, 1965; Myers et al., 1965) and in laboratory animals (Guitton et al., 2003; Jastreboff et al., 1988; Mongan et al., 1973; Stolzberg et al., 2012). In attempts to understand the underlying mechanisms, researchers have extensively studied functional alterations caused by NaSal in the cochlea (Cazals et al., 1998; Durrant et al., 1998; Evans and Borerwe, 1982; Fitzgerald et al., 1993; Kujawa et al., 1992; Lobarinas et al., 2006; Muller et al., 2003), central auditory pathways (Chen et al., 2013; Chen and Jastreboff, 1995; Eggermont and Kenmochi, 1998; Jastreboff and Sasaki, 1986; Patel and Zhang, 2014; Stolzberg et al., 2012; Wallhausser-Franke, 1997) and non-auditory brain regions (Chen et al., 2012; Wallhausser-Franke et al., 2003). In particular, neuropharmacological actions of NaSal have been examined in detail across different central auditory regions, including the cochlear nucleus (Basta et al., 2008; Wei et al., 2010), the inferior colliculus (Chen and Jastreboff, 1995; Jastreboff and Sasaki, 1986), the medial geniculate body (MGB) (Basta et al., 2008; Su et al., 2012) and the auditory cortex (Su et al., 2009; Yang et al., 2007).

    • Ear

      2013, Haschek and Rousseaux's Handbook of Toxicologic Pathology
    • Ear

      2013, Haschek and Rousseaux's Handbook of Toxicologic Pathology, Third Edition: Volume 1-3
    • Salicylate-induced peripheral auditory changes and tonotopic reorganization of auditory cortex

      2011, Neuroscience
      Citation Excerpt :

      The major effect of systemic salicylate injection on cochlear function in rats observed in this study was a significant alteration in the profile of peripheral input; low and high frequencies became less sensitive following salicylate administration leaving 16 kHz as the dominant input frequency (Fig. 1). Salicylate's effects on OHC function have been evaluated following cochlear perfusion in the guinea pig (Kujawa et al., 1992) as well as systemic administration in the rat (Wang et al., 1984; Ralli et al., 2010). In agreement with the results presented here, both of these studies showed a decrease in DPOAE following salicylate administration at low to moderate intensities (Figs. 1 and 3a).

    • A method for intracochlear drug delivery in the mouse

      2006, Journal of Neuroscience Methods
    View all citing articles on Scopus

    A preliminary report was presented at the Midwinter Research Meeting of the Association for Research in Otolaryngology in February 1991.

    View full text